Management of chronic heart failure: Role of home echocardiography in monitoring care programs

Table 1 Clinical and laboratory parameters of the chronic heart failure patients

	Group A	Group B
Sex (M/F)	31/29	29/29
Age (yr)	77 ± 7	78 ± 6
Weight (kg)	73 ± 16	75 ± 20
Height (cm)	164 ± 4	162 ± 8
Body mass index	28 ± 4	26 ± 6
Systolic blood pressure (mmHg)	140 ± 12	136 ± 10
Diastolic blood pressure (mmHg)	81 ± 8	83 ± 10
Creatinine (mg/dL)	1.8 ± 0.4	1.7 ± 0.6
Azotemia (mg/dL)	62 ± 12	59 ± 10
Uricemia (mg/dL)	6.5 ± 3.0	6.6 ± 2.6
Na (mmol/L)	143 ± 5	141 ± 8
K (mmol/L)	5.0 ± 0.2	4.9 ± 0.8
C-reactive protein (mg/dL)	0.9 ± 0.4	0.9 ± 0.6
B-type natriuretic peptide (pg/dL)	586 ± 260	600 ± 244

Data are expressed as mean ± SD. Differences between groups are not significant.